Dr. Lydia Scarfò is a physician scientist at the B-cell neoplasia Unit and an assistant professor at Università Vita-Salute San Raffaele, Milano, Italy.
June 27, 2025
Video
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
Long Delays Seen in Essential Thrombocythemia Diagnosis After Platelet Rise
A Little Off the Top: the First Step in a Brain Cancer Journey
Just a Little Off the Top: Taking the First Step in the Cancer Journey
A Call to Action for More Inclusive Clinical Trials in Cancer Care